The combined market valuation of eight of the top-10 most valued domestic firms eroded by Rs 79,129.21 crore last week, with Bajaj Finance and ICICI Bank taking the biggest hit, amid a largely bearish trend in equities.
Over the past five trading sessions, select smallcap stocks posted gains of up to 27%. Fermenta Biotech led with a 26% rise, followed by Stallion India Fluorochemicals and Rolex Rings. Sectors such as niche pharma, specialty chemicals, auto components, media, IT, and infrastructure witnessed renewed investor interest. The rally highlights heightened volatility, speculative activity, and rapid price discovery in smaller companies.
Foreign investors have sold over Rs 2.23 lakh crore in 2025, yet domestic institutions and SIP flows have absorbed the shock. Despite heavy FII selling, Indian equity markets remain resilient, supported by consistent retail participation and strong earnings prospects.
Corona Remedies and Wakefit Innovations are set to list amid divergent grey market signals. Corona Remedies commands strong listing expectations backed by robust subscriptions and profitability, while Wakefits muted GMP reflects cautious sentiment towards consumer-facing growth businesses, highlighting current investor preference for earnings visibility and consistency.
The Motilal Oswal 30th Annual Wealth Creation Study (20202025) analyses the top 100 companies in India that have created the most wealth for investors over the last five years. Wealth creation is measured by the increase in market capitalisation, adjusted for corporate actions such as mergers, demergers, buybacks, capital issuance, and dividends.
Silver futures surged past Rs 2,00,000 on MCX, hitting lifetime highs amid strong industrial demand, supply deficits, and supportive monetary conditions. While experts remain bullish on the long-term outlook, some caution that the metal is technically overstretched, making near-term corrections possible.
Wall Street strategists are advising a shift away from the dominant technology giants, suggesting investors buy into less popular sectors like health care, industrials, and energy for 2026. Concerns over Big Tech's lofty valuations and AI spending, amplified by recent earnings reports, are driving this rotation.
Madhu Lunawat-led The Wealth Company Mutual Fund will launch The Wealth Company Gold ETF this week. Here are the key details about the NFO (Source: The Wealth Company Mutual Fund).
So far in FY26, 10 penny stocks have risen sharply, delivering returns ranging from 25% to 515%. Notably, six of these have turned into multibaggers. These standout performers were selected based on specific criteria: market capitalisation below Rs 1,000 crore, share price under Rs 20, and minimum recent trading volume of 5 lakh shares. This strategy focuses on identifying low-priced, actively traded micro-cap stocks demonstrating strong upward momentum. (Data Source: ACE Equity).Penny stocks often attract attention due to their low entry price and the potential for explosive growth. But while the rewards can be impressive, the risks are equally high. These stocks typically carry low liquidity, high volatility, and limited financial transparency. Investors should proceed with caution success in penny stocks requires not just luck, but a clear strategy and strong risk management.
Shiprocket is preparing for a significant initial public offering. The Gurugram-based company aims to raise Rs 2,342 crore through its IPO. Investors and founders are selling shares in the offer-for-sale component. Shiprocket plans to list in the first quarter of fiscal year 2027. The company reported operating revenue growth and a reduced net loss for the six months ended September.
